EUVIMEDEUVIMED entdecken
Crossref

Expression of Human Thrombomodulin by Porcine Endothelium Attenuates Thrombus Formation and Platelet Activation in a Dynamic Shear Flow Model

Megan Dufault iD, Sayed-Amir Sanatkar, Zahra Habibabady iD, Victoria Diaz, Jonathan Schulz iD, Cinthia Gomes Lucas iD, Kevin D Wells iD, Kristin M Whitworth iD, David Ayares, Richard N Pierson

Xenotransplantation · 2026-09 · 33 (5)

DOI: 10.1111/xen.70176 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Xenotransplantation, online erschienen am 15.10.2026. Verfasst von Megan Dufault und 9 weiteren Autor:innen. Beteiligte Einrichtung: Center For Transplantation Sciences, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Thrombomodulin, Platelet Activation, Thrombosis, Transplantation, Heterologous. Die Arbeit nennt 57 Literaturangaben. Gefördert von: Sponsored Research Agreement with Revivicor, National Swine Reagent Resource Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Long term xenografts often fail in association with evidence of coagulation pathway dysregulation, which may be caused in part by the inefficient binding of inactivated protein C (PC) to porcine thrombomodulin (TBM). This study evaluates the effect of human TBM (hTBM) expression by genetically modified pig endothelium on human platelet activation, adhesion, and aggregation within a dynamic in vitro xenoperfusion model. Porcine aortic endothelial cells (PAECs) with a variety of genetic modifications and immortalized human coronary endothelial cells (HCECs) ( n = 9) were cultured to confluence in microfluidic channels and perfused for one hour with human whole blood stained with 0.5 mM Calcein to visualize thrombosis formation. After one hour of perfusion, platelet adhesion (as percent surface area coverage) and aggregation (fluorescence intensity) were significantly reduced in association with human APC (hAPC) pretreatment of GTKO, and with DKO.hCD55.hTBM or 10‐GE ECs relative to GT/DKO ± hCD55 ECs. Fold change in frequency of activated (CD62P+) platelets in channel effluent was significantly decreased in association with GTKO+hAPC (1.5 ± 0.03 p = 0.01, n = 6), and DKO.hCD55.hTBM (1.6 ± 0.03 p = 0.02, n = 12) or 10‐GE ECs (1.3 ± 0.04 p < 0.0001, n = 9) relative to GT/DKO ± hCD55 ECs (1.8 ± 0.07, n = 8). No significant difference was observed between DKO.hCD55.hTBM and GTKO+hAPC. We conclude that, under conditions mimicking microcirculatory flow, hTBM expression confers anti‐thrombotic effects comparable to those with hAPC pretreatment of GTKO ECs. Consequently, hTBM expression is a promising method to inhibit platelet dysregulation in xenotransplant models.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ThrombomodulinPlatelet ActivationThrombosisTransplantation, HeterologousEndothelium, VascularAnimalsHumansSwineBlood PlateletsEndothelial CellsAnimals, Genetically ModifiedProtein CHeterograftsPlatelet Adhesiveness

Stichwörter der Autor:innen

plateletsprotein Cthrombomodulinthrombosisxenotransplantation

Substanzen

ThrombomodulinProtein CTHBD protein, human

Autor:innen und Institutionen

  • Center For Transplantation Sciences, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Columbia Vagelos College of Physicians and Surgeons, New York, New York, USA.
  • Department of Cardiovascular Surgery, University Hospital of Mainz, Mainz, Germany.
  • National Swine Resource and Research Center, Columbia, Missouri, USA.
  • Revivicor, Inc., Blacksburg, Virginia, USA.
  • Division of Cardiac Surgery, Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts, USA.

ORCID-Profile: Megan Dufault, Zahra Habibabady, Jonathan Schulz, Cinthia Gomes Lucas, Kevin D Wells, Kristin M Whitworth

Förderung

  • Sponsored Research Agreement with Revivicor
  • National Swine Reagent Resource Center

Zitieren

APA

Dufault, M., Sanatkar, S. A., Habibabady, Z., Diaz, V., Schulz, J., Gomes Lucas, C., Wells, K. D., Whitworth, K. M., Ayares, D., & Pierson, R. N. (2026). Expression of Human Thrombomodulin by Porcine Endothelium Attenuates Thrombus Formation and Platelet Activation in a Dynamic Shear Flow Model. Xenotransplantation, 33(5). https://doi.org/10.1111/xen.70176

Vancouver

Dufault M, Sanatkar SA, Habibabady Z, Diaz V, Schulz J, Gomes Lucas C, et al. Expression of Human Thrombomodulin by Porcine Endothelium Attenuates Thrombus Formation and Platelet Activation in a Dynamic Shear Flow Model. Xenotransplantation. 2026;33(5). doi:10.1111/xen.70176

BibTeX
@article{Dufault2026,
  author = {Dufault, Megan and Sanatkar, Sayed-Amir and Habibabady, Zahra and Diaz, Victoria and Schulz, Jonathan and Gomes Lucas, Cinthia and Wells, Kevin D and Whitworth, Kristin M and Ayares, David and Pierson, Richard N},
  title = {Expression of Human Thrombomodulin by Porcine Endothelium Attenuates Thrombus Formation and Platelet Activation in a Dynamic Shear Flow Model},
  journal = {Xenotransplantation},
  year = {2026},
  volume = {33},
  number = {5},
  doi = {10.1111/xen.70176}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche